Early Embryonic Expression of Murine Coagulation System Components

Summary

The development of the embryonic coagulation system, and its contribution to the maintenance of vascular integrity during the formation of embryonic blood vessels, remain poorly understood. We have characterized the temporal expression patterns of 27 hemostasis-related genes during murine development. We show that, although most coagulation and fibrinolysis-related factors are expressed coordinately b 7.5 dpc, several, including FIX, FXII and PAI2, are not detectable until later developmental timepoints. The expression of hemostasis-specific genes prior to the formation of a functional circulatory system supports the view that some coagulation factors have additional non-hemostatic functions during development. In addition, the discordant expression of some factors suggests that the embryonic hemostatic system may be distinct from that of the adult. These analyses will help to elucidate the regulation of hemostasis during embryonic/vascular development, and will provide a framework to facilitate the interpretation of gene inactivation studies.

Keywords

Embryo - hemostasis - vascular development - knock-out

• References

• 1 Broze Jr. G. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coag Fibrinolys 1995; 06: S7-S13.
• 2 Hajjar KA. Changing concepts in fibrinolysis. Curr Opin Hematol 1995; 02: 345-50.
• 3 Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 1997; 78: 386-91.
• 4 Andrew M, Paes B. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12: 95-104.
• 5 Andrew M. The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Semin Perinatol 1997; 21: 70-85.
• 6 Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen D, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-72.
• 7 Ries M. Molecular and functional properties of fetal plasminogen and its possible influence on clot lysis in the neonatal period. Semin Thromb Hemost 1997; 23: 247-52.
• 8 Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 1997; 22: 251-6.
• 9 Noden D. Embryonic origins and assembly of blood vessels. Am Rev Resp Dis 1989; 140: 1097-103.
• 10 Noden D. Development of craniofacial blood vessels. In: The development of the vascular system. Feinberg R, Sherer G, Auerbach R. New York: 1991: 1-24.
• 11 Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-4.
• 12 Risau W. Differentiation of endothelium. Faseb J 1995; 09: 926-33.
• 13 Risau W. Vasculogenesis, angiogenesis and endothelial cell differentiation during embryo development. In: The development of the vascular system. Feinberg R, Sherer G, Auerbach R. New York: Karger; 1991: 58-68.
• 14 Risau W. Development and differentiation of endothelium. Kidney Int Suppl 1998; 67: S3-6.
• 15 Soifer SJ, Peters KG, O’Keefe J, Coughlin SR. Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am J Pathol 1994; 144: 60-9.
• 16 Darrow AL, Fung-Leung WP, Ye RD, Santulli RJ, Cheung WM, Derian CK, Burns CL, Damiano BP, Zhou L, Keenan CM, Peterson PA, Andrade-Gordon P. Biological consequences of thrombin receptor deficiency in mice. Thromb Haemost 1996; 76: 860-6.
• 17 Cui J, O’Shea KS, Purkayastha A, Saunders TL, Ginsburg D. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 1996; 384: 66-8.
• 18 Connolly A, Ishihara H, Kahn M, Farese Jr R, Coughlin S. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996; 381: 516-9.
• 19 Healy A, Rayburn H, Rosenberg R, Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci (USA) 1995; 92: 850-4.
• 20 Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383: 73-5.
• 21 Bugge T, Xiao Q, Kombrinck K, Flick M, Holmback K, Danton M, Colbert M, Witte D, Fujikawa K, Davie E, Degen J. Fatal embryonic bleeding events in mice lacking tissue factor, the cell associated initiator of blood coagulation. Proc Natl Acad Sci (USA) 1996; 93: 6258-63.
• 22 Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze Jr GJ. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88: 1583-7.
• 23 Wiles MV. Embryonic stem cell differentiation in vitro. Methods Enzymol 1993; 225: 900-18.
• 24 Keller G, Kennedy M, Papayannopoulou T, Wiles M. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 1993; 13: 473-86.
• 25 Weiss M, Keller G, Orkin S. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes & Dev 1994; 08: 1184-97.
• 26 Vittet D, Prandini M, Berthier R, Schweitzer A, Martin-Sisteron H, Uzqn G, Dejana E. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Development 1996; 88: 3424-31.
• 27 Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 1995; 203: 80-92.
• 28 Wang M, Clark R, Bautch V. Embryonic stem-cell derived cystic embyroid bodies from vascular channels: an in vitro model of blood vessel development. Development 1992; 114: 303-16.
• 29 Risau W, Sariola H, Zerwes HG, Sasse J, Ekblom P, Kemler R, Doetschman T. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 1988; 102: 471-8.
• 30 Luther T, Flossel C, Mackman N, Bierhaus A, Kasper M, Albrecht S, Sage EH, Iruela-Arispe L, Grossmann H, Strohlein A, Zhang Y, Nawroth PP, Carmeliet P, Loskutoff DJ, Muller M. Tissue factor expression during human and mouse development. Am J Pathol 1996; 149: 101-13.
• 31 Sun WY, Witte DP, Degen JL, Colbert MC, Burkart MC, Holmback K, Xiao Q, Bugge TH, Degen SJ. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci (USA) 1998; 95: 7597-602.
• 32 Imada S, Yamaguchi H, Nagumo M, Katayanagi S, Iwasaki H, Imada M. Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays. Dev Biol 1990; 140: 113-22.
• 33 Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS. Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost 1999; 81: 177-88.
• 34 Xue J, Wu Q, Westfield LA, Tuley EA, Lu D, Zhang Q, Shim K, Zheng X, Sadler JE. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci (USA) 1998; 95: 7603-7.
• 35 Huang ZF, Broze Jr G. Consequences of tissue factor pathway inhibitor gene- disruption in mice. Thromb Haemost 1997; 78: 699-704.
• 36 Mueller B, Reisfeld R, Edgington T, Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci (USA) 1992; 89: 11832-6.
• 37 Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 1998; 140: 1241-53.
• 38 Fischer EG, Riewald M, Huang H-Y, Miyagi H, Kubota Y, Mueller BM, Ruf W. Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. J Clin Invest 1999; 104: 1213-21.
• 39 Gasic G, Arenas C, Gasic T, Basic G. Coagulation factors X, Xa and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci (USA) 1992; 89: 2317-20.
• 40 Zhang Y, Weiler-Guettler H, Chen J, Wilhelm O, Deng Y, Qiu F, Nakagawa K, Klevesath M, Wilhelm S, Bohrer H, Nakagawa M, Graeff H, Martin E, Stern D, Rosenberg R, Ziegler R, Nawroth P. Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J Clin Invest 1998; 101: 1301-9.
• 41 Romer J, Bugge T, Pyke C, Lund L, Flick M, Degen J, Dano K. Impaired wound healing in mice with a disrupted plasminogen gene. Nature Medicine 1996; 02: 287-92.
• 42 Carmeliet P, Bouche A, De Clercq C, Janssen S, Pollefeyt S, Wyns S, Mulligan R, Collen D. Biological effects of disruption of tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-1 genes in mice. Ann N Y Acad Sci 1995; 748: 367-81.
• 43 Stitt TN, Conn G, Gore M, Lai C, Bruno J, Radziejewski C, Mattsson K, Fisher J, Gies DR, Jones PF. et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 1995; 80: 661-70.
• 44 O’Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-28.
• 45 Cirino G, Cicala C, Bucci M, Sorrentino L, Ambrosini G, DeDominicis G, Altieri D. Factor Xa as an interface between coagulation and inflammation. J Clin Invest 1997; 99: 2446-51.
• 46 Esmon C, Taylor F, Snow T. Inflammation and coagulation: linked processes potentially mediated by protein C. Thromb Haemost 1991; 66: 160-5.
• 47 Monsonego A, Mizrahi T, Eitan S, Moalem G, Bardos H, Adany R, Schwartz M. Factor XIIIa as a nerve-associated transglutaminase. Faseb J 1998; 12: 1163-71.
• 48 Schmaier AH. Contact activation: a revision. Thromb Haemost 1997; 78: 101-7.
• 49 Tkachuk V, Stepanova V, Little PJ, Bobik A. Regulation and role of urokinase plasminogen activator in vascular remodelling. Clin Exp Pharmacol Physiol 1996; 23: 759-65.
• 50 Kundu RK, Sangiorgi F, Wu LY, Kurachi K, Anderson WF, Maxson R, Gordon EM. Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice. Blood 1998; 92: 168-74.
• 51 Bi L, Lawler A, Antonarakis S, High K, Gerhart J, Kazazian H. Targeted disruption of the mouse factor VIII gene produces a model of hemophilia A. Nat Genet 1995; 69: 21-4.
• 52 Ranganathan G, Blatti SP, Subramaniam M, Fass DN, Maihle NJ, Getz MJ. Cloning of murine tissue factor and regulation of gene expression by transforming growth factor type beta 1. J Biol Chem 1991; 266: 496-501.
• 53 Murakawa M, Okamura T, Kamura T, Shibuya T, Harada M, Niho Y. Diversity of primary structures of the carboxy-terminal regions of mammalian fibrinogen A alpha-chains. Characterization of the partial nucleotide and deduced amino acid sequences in five mammalian species; rhesus monkey, pig, dog, mouse and Syrian hamster. Thromb Haemost 1993; 69: 351-60.
• 54 Degen SJ, Schaefer LA, Jamison CS, Grant SG, Fitzgibbon JJ, Pai JA, Chapman VM, Elliott RW. Characterization of the cDNA coding for mouse prothrombin and localization of the gene on mouse chromosome 2. DNA Cell Biol 1990; 09: 487-98.
• 55 Bugge TH, Suh TT, Flick MJ, Daugherty CC, Romer J, Solberg H, Ellis V, Dano K, Degen JL. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem 1995; 270: 16886-94.
• 56 Idusogie E, Rosen E, Geng JP, Carmeliet P, Collen D, Castellino FJ. Characterization of a cDNA encoding murine coagulation factor VII. Thromb Haemost 1996; 75: 481-7.
• 57 Elder B, Lakich D, Gitschier J. Sequence of the murine factor VIII cDNA. Genomics 1993; 16: 374-9.
• 58 Nichols WC, Cooney KA, Mohlke KL, Ballew JD, Yang A, Bruck ME, Reddington M, Novak EK, Swank RT, Ginsburg D. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene. Blood 1994; 83: 3225-31.
• 59 Sarkar G, Koeberl DD, Sommer SS. Direct sequencing of the activation peptide and the catalytic domain of the factor IX gene in six species. Genomics 1990; 06: 133-43.
• 60 Rosen E. Personal Communication. 1997
• 61 Genbank Accession number X99571.
• 62 Nonaka M, Matsuda Y, Shiroishi T, Moriwaki K, Natsuume-Sakai S. Molecular cloning of the b subunit of mouse coagulation factor XIII and assignment of the gene to chromosome 1: close evolutionary relationship to complement factor H. Genomics 1993; 15: 535-42.
• 63 Wu JK, Sheffield WP, Blajchman MA. Molecular cloning and cell-free expression of mouse antithrombin III. Thromb Haemost 1992; 68: 291-6.
• 64 Tada N, Sato M, Tsujimura A, Iwase R, Hashimoto-Gotoh T. Isolation and characterization of a mouse protein C cDNA. J Biochem (Tokyo) 1992; 111: 491-5.
• 65 Fukudome K, Esmon CT. Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR). The structural and functional conservation in human, bovine, and murine EPCR. J Biol Chem 1995; 270: 5571-5.
• 66 Chu MD, Sun J, Bird P. Cloning and sequencing of a cDNA encoding the murine vitamin K-dependent protein S. Biochim Biophys Acta 1994; 1217: 325-8.
• 67 Dittman WA, Majerus PW. Sequence of a cDNA for mouse thrombomodulin and comparison of the predicted mouse and human amino acid sequences. Nucleic Acids Res 1989; 17: 802.
• 68 Genbank. Accession number L03529.
• 69 Genbank. Accession number U92972.
• 70 Ong K, Conway EM, Schuh AC. Unpublished data. 1997
• 71 Degen SJ, Bell SM, Schaefer LA, Elliott RW. Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17. Genomics 1990; 08: 49-61.
• 72 Rickles RJ, Darrow AL, Strickland S. Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation. J Biol Chem 1988; 263: 1563-9.
• 73 Belin D, Vassalli JD, Combepine C, Godeau F, Nagamine Y, Reich E, Kocher HP, Duvoisin RM. Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur J Biochem 1985; 148: 225-32.
• 74 Kristensen P, Eriksen J, Blasi F, Dano K. Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract. J Cell Biol 1991; 115: 1763-71.
• 75 Prendergast GC, Diamond LE, Dahl D, Cole MD. The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol Cell Biol 1990; 10: 1265-9.
• 76 Liang Z, Cooper A, DeFord ME, Carmeliet P, Collen D, Castellino FJ. Rosen Cloning and characterization of a cDNA encoding murine coagulation factor X. Thromb Haemost 1998; 80: 87-91.
• 77 Menoud PA, Sappino N, Boudal-Khoshbeen M, Vassalli JD, Sappino AP. The kidney is a major site of alpha(2)-antiplasmin production. J Clin Invest 1996; 97: 2478-84.
• 78 Conway EM, Schuh AC. Unpublished data, 1997.